Foley Hoag Represents The Valens Company in CDN$32.3M 'Bought Deal' Offering

April 6, 2022

Foley Hoag LLP represented The Valens Company (TSX: VLNS; Nasdaq: VLNS), a leading manufacturer of cannabis products, in its underwritten “bought deal” offering of units resulting in gross proceeds to the company of approximately CDN$32.3 million, including the exercise of the underwriters’ over-allotment option.

The Valens Company is a manufacturer of cannabis products. The company provides proprietary cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer packaged goods. The Valens Company's products are formulated for the medical, health and wellness, and recreational consumer segments, and are offered across all cannabis product categories with a focus on quality and innovation.  The company also manufactures, distributes, and sells a wide range of CBD products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to Australia through its subsidiary Valens Australia.

Foley Hoag attorneys Ryan Rourke Reed, Stacie Aarestad, Caroline Samp, Zachery Nelson, Silvia Mavares, Jesse Alderman and Nick Romanos represented The Valens Company in the transaction.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and business services professionals contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.